SCHEMBL28066258

SCHEMBL28066258

COc1ccccc1Oc1ccc(C(=O)O)c2ccccc12

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 2/20 0.68
CDC25B P30305 2/20 0.63
PLK1 P53350 1/20 0.54
HPGDS O60760 1/20 0.53
CYP2C9 P11712 2/20 0.51
HIF1A Q16665 1/20 0.51
HPGD P15428 4/20 0.49
MAPT P10636 3/20 0.49
KMT2A Q03164 2/20 0.49
ALDH1A1 P00352 5/20 0.48
HSD17B10 Q99714 2/20 0.48
CYP1A2 P05177 1/20 0.48
CYP3A4 P08684 1/20 0.48
STAT6 P42226 1/20 0.48
GAA P10253 1/20 0.47
LMNA P02545 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47
KDM4E B2RXH2 3/20 0.46
TDP1 Q9NUW8 1/20 0.46
TTR P02766 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4469856 0.88 CDC25B (0.78) HTTCDC25BPLK1HPGDSCYP2C9
SCHEMBL10420596 0.88 CDC25B (0.57) HTTCDC25BPLK1HPGDSCYP2C9
Hydrochloric Acid SCHEMBL11445757 0.86 CDC25B (0.76) HTTCDC25BPLK1HPGDSCYP2C9
Cyanide SCHEMBL11198616 0.83 CDC25B (0.71) HTTCDC25BPLK1HPGDSCYP2C9
SCHEMBL7560388 0.83 CDC25B (0.88) HTTCDC25BPLK1HPGDSCYP2C9
SCHEMBL7536268 0.82 NR4A1 (0.59) CDC25BHPGDKMT2AALDH1A1HSD17B10
SCHEMBL4103770 0.81 CDC25B (0.68) HTTCDC25BPLK1HPGDSCYP2C9
SCHEMBL3384527 0.81 HTT (1.00) HTTCDC25BCYP2C9HPGDMAPT
SCHEMBL28066296 0.81 CDC25B (0.57) HTTCDC25BPLK1HPGDSCYP2C9
SCHEMBL28828357 0.81 CXCL8 (0.50) HTTCDC25BPLK1ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105473548-A Amide derivatives as lysophosphatidic acid receptor antagonists TAKEDA PHARMACEUTICALS CO 2016-04-06 CN disclosed